Home » BARR ANNOUNCES OFFER OF $2.2 BILLION FOR PLIVA
BARR ANNOUNCES OFFER OF $2.2 BILLION FOR PLIVA
Drugmaker Barr Pharmaceuticals has announced that the supervisory board of Croatia-based Pliva has endorsed Barr's proposal to make a tender offer to Pliva's shareholders to purchase 100% of the shares of the company for approximately $2.2 billion in cash.
Under the terms of its proposal, Barr would pay Pliva shareholders who tender their shares approximately $24.42 per share.
Barr anticipates that it will launch a tender offer for Pliva shares later this year, upon receiving Hart-Scott-Rodino clearance in the U.S., as well as a successful regulatory review in Germany and approval by the Croatian Agency for Supervision of Financial Services, the company said.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May